Nhs Uk Has Adopted Cells4life’s Cord Blood Volume Reduction Method

By Author: KeastDarren
Total Articles: 1
Comment this article

Posted by Cells4Life on Jun 23, 2013 in Cells4Life Updates | 0 comments

The National Health Service (NHS) Cord Blood Bank in the United Kingdom has adopted Cells4Life Gold service method of cord blood volume reduction using Thermogenesis AXP System.

The NHS manages six umbilical cord blood facilities and a cord blood storage bank in the UK.

The upgrade by the NHS from the Sepax system to the more advanced Thermogenesis AXP system will ensure a number of benefits for the country’s cord blood bank. In comparison to the Sepax System, cord blood units processed using AXP are richer in Mononuclear Cells (MNCs) than units conventionally processed having similar Total Nucleated Cell Counts (TNC Counts). Stem cell recovery of units is greater than 97%, which is higher than Sepax and any other cord blood processing systems.

Cord Blood is the blood that remains in the placenta and umbilical cord after the baby is born. It is rich in stem cells which can help to cure and treat many life threatening diseases. The stem cells found in cord blood restore the function of the patient’s immune system and blood ...
... producing systems. It is an alternative to using bone marrow with the advantage of being immediately available if required for treatment.

The United Kingdom Department of Health in collaboration with NHSBT has established new targets for both cell collection activity and cell counts processed from cord blood, and are providing expanded funding to support cord blood collection programs over the next three years. These new targets mean that collection could potentially double in the UK.

Thermogenesis (NASDAQ: KOOL) is a developer of separation, preservation and storage technologies for human blood and tissue.

The lifesaving power of umbilical cord blood stem cells and the regenerative healing of cord tissue is no longer a secret. As stem cell treatments and research advance, more and more parents are opting to bank their newborn baby’s cord blood and tissue. Find out how stem cells are being used in medicine today.

Umbilical cord blood is the blood remaining in the cord after your baby has been born and the cord has been cut and clamped. It contains valuable stem cells that can be used in a variety of medical treatments such as regenerating the immune system after chemotherapy. Stem cells are known as ‘the building blocks of life’. They have the unique ability to become other types of cells in the body such as the blood, nerve cells, muscle, bone, and cartilage.

Why are umbilical stem cells so valuable?

Cord blood stem cells can only be collected at birth, so it is important to make the decision to do cord tissue storage several weeks before your due date.

Cord Tissue stored at birth have many advantages – they are readily available for your family if needed, they are considered to be the ‘youngest and freshest’ type of stem cell, and importantly there is a greater potential of a stem cell match between siblings.

Stem cells from the cord blood have been used for more than 20 years for the treatment of a number of disorders of the blood such as leukemia, lymphoma and thalassemia, which previously had been treated with bone marrow.

The umbilical cord blood collection process

After the safe delivery of your child, your obstetrician or midwife cleans the umbilical cord (with the materials provided in the Cells4Life kit) and inserts the blood bag needle into the umbilical vein. The blood flows into the bag by gravity. The blood bag tubing is clamped, sealed and labeled to await courier collection. The whole process takes only a few minutes and causes no pain for mother or baby.

Darren Keast is the author of this article on Cord blood banking.Find more information, about Tissue Typing Service here